SV Health Investors
Investor profile
Venture capital
Deals
6
distinct rounds
Companies
5
backed
Active span
2021–2025
5 yrs
Total round €
€377M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Jeito Capital3
- EQT Life Sciences2
- Janus Henderson Investors2
- MRL Ventures Fund2
- Omega Funds2
- Samsara Biocapital2
- Andera Partners1
- Avidity Partners1
- Bain Capital Life Sciences1
- British Patient Capital1
- DCVC Bio1
- Earlybird Venture Capital1
- Fidelity Management & Research Company LLC1
- Invus1
- IP Group PLC1
- Lightstone Ventures1
- Lilly1
- M Ventures1
- Monashee Investment Management LLC1
- Novartis Venture Fund1
- Ono Venture Investment (OVI)1
- Pfizer Ventures1
- Piper Heartland Healthcare Capital1
- Point72 Ventures1
- RA Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
| EyeBiotech | UK | 2 | €117M |
| Artios | UK | 1 | €99M |
| Perfuze | Ireland | 1 | €22M |
| Alchemab Therapeutics | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Artios | Series D+ | €99M | 2025-11 |
| EyeBiotech | Series A | €60M | 2023-11 |
| EyeBiotech | Series A | €57M | 2022-02 |
| Perfuze | Other | €22M | 2025-03 |